Kaspar Broch

5.8k total citations · 2 hit papers
85 papers, 2.0k citations indexed

About

Kaspar Broch is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Kaspar Broch has authored 85 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 26 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Kaspar Broch's work include Cardiovascular Function and Risk Factors (19 papers), Transplantation: Methods and Outcomes (15 papers) and Cardiac Valve Diseases and Treatments (14 papers). Kaspar Broch is often cited by papers focused on Cardiovascular Function and Risk Factors (19 papers), Transplantation: Methods and Outcomes (15 papers) and Cardiac Valve Diseases and Treatments (14 papers). Kaspar Broch collaborates with scholars based in Norway, Sweden and Denmark. Kaspar Broch's co-authors include Lars Gullestad, Thor Ueland, Pål Aukrust, Johannes R. Hov, Marius Trøseid, Geir Øystein Andersen, Svend Aakhus, Annika E. Michelsen, Ola Kleveland and Bjørn Bendz and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Kaspar Broch

80 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

2016 288 citations Ola Kleveland, Gabor Kunszt et al. profile →
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions

2020 260 citations Marius Trøseid, Geir Øystein Andersen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kaspar Broch Norway	22	879	748	450	398	364	85	2.0k
Kevin Shrestha United States	27	1.6k 1.8×	471 0.6×	235 0.5×	302 0.8×	333 0.9×	53	2.7k
Marcus Fischer Germany	25	944 1.1×	431 0.6×	176 0.4×	264 0.7×	504 1.4×	119	2.3k
Geir Øystein Andersen Norway	28	931 1.1×	721 1.0×	284 0.6×	206 0.5×	259 0.7×	92	2.1k
Allen G. Borowski United States	25	1.6k 1.8×	393 0.5×	222 0.5×	280 0.7×	362 1.0×	53	2.5k
Mitsushige Nishikawa Japan	31	703 0.8×	876 1.2×	287 0.6×	301 0.8×	385 1.1×	158	3.1k
Takayuki Inomata Japan	25	1.4k 1.5×	351 0.5×	210 0.5×	155 0.4×	316 0.9×	156	2.0k
Shinae Kang South Korea	25	695 0.8×	512 0.7×	218 0.5×	342 0.9×	417 1.1×	74	2.4k
Thorsten M. Leucker United States	21	674 0.8×	451 0.6×	240 0.5×	129 0.3×	520 1.4×	77	1.6k
Tayfun Eyıleten Türkiye	33	869 1.0×	362 0.5×	409 0.9×	443 1.1×	504 1.4×	71	3.1k
Justin M. Canada United States	21	1.3k 1.5×	488 0.7×	177 0.4×	320 0.8×	285 0.8×	73	2.0k

Countries citing papers authored by Kaspar Broch

Since Specialization

Citations

This map shows the geographic impact of Kaspar Broch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaspar Broch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaspar Broch more than expected).

Fields of papers citing papers by Kaspar Broch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaspar Broch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaspar Broch. The network helps show where Kaspar Broch may publish in the future.

Co-authorship network of co-authors of Kaspar Broch

This figure shows the co-authorship network connecting the top 25 collaborators of Kaspar Broch. A scholar is included among the top collaborators of Kaspar Broch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaspar Broch. Kaspar Broch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Øverland, Britt, Christina Bendz, Annika E. Michelsen, et al.. (2025). Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation. European Journal of Internal Medicine. 139. 106363–106363.

Woxholt, Sindre, Thor Ueland, Pål Aukrust, et al.. (2024). Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI. International Journal of Cardiology. 418. 132613–132613. 1 indexed citations

Murbræch, Klaus, Rune Andersen, Narve Moe, et al.. (2024). Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Heart. 111(3). 125–132. 1 indexed citations

Holt, Margrethe Flesvig, et al.. (2024). The association between body mass index, exercise capacity, and health-related quality of life in heart transplant recipients. SHILAP Revista de lepidopterología. 3. 1379695–1379695. 1 indexed citations

Kong, Xiang Yi, Kaspar Broch, Lars Gullestad, et al.. (2024). Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction. International Journal of Molecular Sciences. 25(16). 9014–9014. 2 indexed citations

Bollano, Entela, Hans Eiskjær, Finn Gustafsson, et al.. (2024). Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial. The Journal of Heart and Lung Transplantation. 43(12). 1948–1959. 2 indexed citations

Andersen, Rune, S Birkeland, Morten Svalebjørg, et al.. (2023). Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison of changes in hemodynamics and functional capacity. Pulmonary Circulation. 13(1). e12199–e12199. 7 indexed citations

Remme, Espen W., Otto A. Smiseth, Richard Massey, et al.. (2023). Non-invasive myocardial work in aortic stenosis: validation and improvement in left ventricular pressure estimation. European Heart Journal - Cardiovascular Imaging. 25(2). 201–212. 5 indexed citations

Raju, Sajan C., Kaspar Broch, Cristiane C.K. Mayerhofer, et al.. (2023). Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure. Frontiers in Cardiovascular Medicine. 10. 1160030–1160030. 5 indexed citations

10.

Skjølsvik, Eystein, Øyvind Lie, Monica Chivulescu, et al.. (2021). Progression of cardiac disease in patients with lamin A/C mutations. European Heart Journal - Cardiovascular Imaging. 23(4). 543–550. 7 indexed citations

11.

Øverland, Britt, Christina Bendz, Svend Aakhus, et al.. (2021). Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 204(5). 573–582. 72 indexed citations

12.

Rolid, Katrine, et al.. (2021). Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial. The Journal of Heart and Lung Transplantation. 40(5). 359–367. 12 indexed citations

13.

Mayerhofer, Cristiane C.K., Martin Kummen, Kristian Holm, et al.. (2020). Low Fibre Intake is Associated with Gut Microbiota Alterations in Chronic Heart Failure. ESC Heart Failure. 7(2). 456–466. 65 indexed citations

14.

Trøseid, Marius, Cristiane C.K. Mayerhofer, Kaspar Broch, et al.. (2019). The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection. The Journal of Heart and Lung Transplantation. 38(10). 1097–1103. 19 indexed citations

15.

Kleveland, Ola, Thor Ueland, Gabor Kunszt, et al.. (2018). Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction. International Journal of Cardiology. 271. 1–7. 27 indexed citations

16.

Nymo, Ståle H., Pål Aukrust, John Kjekshus, et al.. (2017). Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure. JACC Heart Failure. 5(4). 256–264. 25 indexed citations

17.

Broch, Kaspar, Erik T. Askevold, Erik Gjertsen, et al.. (2014). The Effect of Rosuvastatin on Inflammation, Matrix Turnover and Left Ventricular Remodeling in Dilated Cardiomyopathy: A Randomized, Controlled Trial. PLoS ONE. 9(2). e89732–e89732. 10 indexed citations

18.

Broch, Kaspar, Thor Ueland, Ståle H. Nymo, et al.. (2012). Soluble ST2 is Associated with Adverse Outcome in Patients with Heart Failure of Ischaemic Aetiology. European Journal of Heart Failure. 14(3). 268–277. 106 indexed citations

19.

Helle-Valle, Thomas, et al.. (2011). Abstract 8551: Left Atrial Strain by Speckle Tracking Echocardiography In Patients with Heart Failure - An Independent and Incremental Predictor of Cardiac Death or Need of Heart Transplantation. Circulation. 124(suppl_21). 2 indexed citations

20.

Arora, Satish, Pål Aukrust, Thor Ueland, et al.. (2009). Elevated Serum Uric Acid Levels Following Heart Transplantation Predict All-Cause and Cardiac Mortality. European Journal of Heart Failure. 11(10). 1005–1013. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact